Polymeric nanoparticles as an oral delivery system for biocontrol agents for the brushtail possum (trichosurus vulpecula)

New Zealand Veterinary Journal

Volumn 57, Issue 6, 2009, Pages 370-377

  McDowell, A ^a   Rades, T ^a   Tucker, I G ^a   McLeod, B J ^b  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b INVERMAY AGRICULTURAL CENTRE   (New Zealand)

Author keywords

Biological control; Brushtail possum; Insulin; Nanoparticles; Oral delivery; Pharmacokinetics; Radioimmunoassay; Trichosurus vulpecula

Indexed keywords

2 CYANOACRYLIC ACID ETHYL ESTER; CYANOACRYLATE DERIVATIVE; ETHYL 2-CYANOACRYLATE; INSULIN; NANOPARTICLE;

ANIMAL; ANIMAL DISEASE; ARTICLE; BIOAVAILABILITY; BIOLOGICAL PEST CONTROL; BLOOD; CECUM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; METHODOLOGY; NEW ZEALAND; ORAL DRUG ADMINISTRATION; RADIOIMMUNOASSAY; RANDOMIZED CONTROLLED TRIAL; REVERSED PHASE LIQUID CHROMATOGRAPHY; TRICHOSURUS;

ADMINISTRATION, ORAL; ANIMALS; BIOLOGICAL AVAILABILITY; CECUM; CHROMATOGRAPHY, REVERSE-PHASE; CYANOACRYLATES; DRUG DELIVERY SYSTEMS; INJECTIONS, INTRAVENOUS; INSULIN; NANOPARTICLES; NEW ZEALAND; PEST CONTROL, BIOLOGICAL; RADIOIMMUNOASSAY; TRICHOSURUS;

PHALANGERIDAE; TRICHOSURUS; TRICHOSURUS VULPECULA;

EID: 74549114730     PISSN: 00480169     EISSN: 11760710     Source Type: Journal    
DOI: 10.1080/00480169.2009.64731     Document Type: Article

References (30)

1. Aboubakar M, Couvreur P, Pinto- Alphandary H, Gouritin B, Lacour B, Farinotti R, Puisieux F, Vauthier C. Insulin-loaded nanocapsules for oral administration: In vitro and in vivo investigation. Drug Development Research 49, 109–17, 2000
2. Clout MN, Ericksen K. Anatomy of a disastrous success: The brushtail possum as an invasive species. In: Montague TL (ed) The Brushtail Possum: Biology, Impact and Management of an Introduced Marsupial. Pp 1–9. Manaaki Whenua Press, Lincoln, NZ, 2000
3. Crawford JL. Ovulation and the associated changes in cul-de-sac tissue in the brushtail possum (Trichosurus vulpecula). PhD thesis, University of Otago, Dunedin, NZ, 1997
4. Cruz T, Gaspar R, Donato A, Lopes C. Interaction between polyalkylcyanoacrylate nanoparticles and peritoneal macrophages: MTT metabolism, NBT reduction, and NO production. Pharmaceutical Research 14, 73–9, 1997
5. Damge C, Vranckx H, Balschmidt P, Couvreur P. Poly(alkyl cyanoacrylate) nanospheres for oral administration of insulin. Journal of Pharmaceutical Sciences 86, 1403–9, 1997
6. Demoy M, Andreux JP, Weingarten C, Gouritin B, Couvreur P, et al. Spleen capture of nanoparticles: influence of animal species and surface characteristics. Pharmaceutical Research 16, 37–41, 1999
7. Draper N, Smith H. The examination of residuals. Applied Regression Analysis. Pp 86–100. John Wiley and Sons Inc, New York, USA, 1968
8. Duckworth JA, Wilson K, Cui XL, Molinia FC, Cowan PE. Immunogenicity and contraceptive potential of three infertility-relevant zona pellucida 2 epitopes in the marsupial brushtail possum (Trichosurus vulpecula). Reproduction 133, 177–86, 2007
9. Eymann J, Herbert CA, Thomson BP, Trigg TE, Cooper DW, Eckery DC. Effects of deslorelin implants on reproduction in the common brushtail possum (Trichosurus vulpecula). Reproduction, Fertility, and Development 19, 899–909, 2007
10. Gautier JC, Grangier JL, Barbier A, Dupont P, Dussossoy D, Pastor G and Couvreur P. Biodegradable nanoparticles for subcutaneous administration of growth hormone release factor (hGRF). Journal of Controlled Release 20, 67–78, 1992
11. Hillery AM, Toth I, Florence AF. Copolymerized peptide particles. Part 2. Oral uptake of a novel copolymeric nanoparticulate delivery system for peptides. Journal of Controlled Release 42, 65–73, 1996
12. Kerle JA. Variation in the ecology of Trichosurus: its adaptive significance. In: Smith AP, Hume ID (eds). Possums and Gliders. Pp 115–28. Surrey Beatty and Sons Pty Limited, Chipping Norton, NSW, Australia, 1984
13. Li CL, Deng YJ. Oil-based formulations for oral delivery of insulin. Journal of Pharmacy and Pharmacology 56, 1101–7, 2004
14. Mahato RI, Narang AS, Thoma L, Miller DD. Emerging trends in oral delivery of peptide and protein drugs. Critical Reviews in Therapeutic Drug Carrier Systems 20, 153–214, 2003
15. McDowell A, McLeod BJ, Thompson EG, Tucker IG. A morphometric study of the gastrointestinal tract of the common brushtail possum in southern New Zealand. Australian Mammalogy 27, 61–7, 2005
16. McDowell A, McLeod BJ, Rades T, Tucker IG. Application of pharmaceutical drug delivery for biological control of the common brushtail possum in New Zealand: a review. Wildlife Research 33, 679–89, 2006
17. McLeod BJ, Thompson EG, Crawford JL, Shackell GH. Successful group housing of wild-caught brushtail possums (Trichosurus vulpecula). Animal Welfare 6, 67–76, 1997
18. McLeod BJ, Zhang H, Huang L, Thompson EG, Butt AG, Tucker IG. An in situ single-pass perfusion model for assessing absorption across the intestinal mucosa of the brushtail possum. New Zealand Veterinary Journal 53, 234–41, 2005
19. Michel C, Defontaine L, Aprahamian M, Couvreur P, Damgé C. Insulin nanocapsules: variations in the biological response depending on the administration site along the digestive tract. In: Whateley TL (ed). Microencapsulation of Drugs. Pp 233–42. Harwood Academic Publishers, Chur, Switzerland, 1992
20. Moghimi SM, Hunter AC, Murray JC. Long-circulating and target-specific nanoparticles: Theory to practice. Pharmacological Reviews 53, 283–318, 2001
21. Purves RD. Optimum numerical integration methods for estimation of area-under-the-curve (AUC) and area-under-the-moment-curve (AUMC). Journal of Pharmacokinetics and Biopharmaceutics 20, 211–26, 1992
22. Schilling RJ, Mitra AK. Pharmacodynamics of insulin following intravenous and enteral administrations of porcine-zinc insulin to rats. Pharmaceutical Research 9, 1003–9, 1992
23. Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. Biodegradable polymeric nanoparticles as drug delivery devices. Journal of Controlled Release 70, 1–20, 2001
24. Vauthier C, Dubernet C, Fattal E, Pinto- Alphandary H, Couvreur P. Poly(alkylcyanoacrylates) as biodegradable materials for biomedical applications. Advanced Drug Delivery Reviews 55, 329–47, 2003
25. Waldhausl WK, Bratuschmarrain PR, Vierhapper H, Nowotny P. Insulin pharmacokinetics following continuous infusion and bolus injection of regular porcine and human insulin in healthy man. Metabolism, Clinical and Experimental 32, 478–86, 1983
26. Watnasirichaikul S, Davies NM, Rades T, Tucker IG. Preparation of biodegradable insulin nanocapsules from biocompatible microemulsions. Pharmaceutical Research 17, 684–9, 2000
27. Watnasirichaikul S, Rades T, Tucker IG, Davies NM. In-vitro release and oral bioactivity of insulin in diabetic rats using nanocapsules dispersed in biocompatible microemulsion. Journal of Pharmacy and Pharmacology 54, 473–80, 2002
28. Wen JY. Barriers to the intestinal absorption of peptides and proteins in the possum (Trichosurus vulpecula). PhD thesis, University of Otago, Dunedin, NZ, 2003
29. Wen JY, Ledger R, McLeod BJ, Davies NM, Butt AG, Tucker IG. Enzymatic degradation of luteinizing hormone-releasing hormone (LHRH) by mucosal homogenates from the intestine of the common brushtail possum (Trichosurus vulpecula). Life Sciences 71, 3019–30, 2002
30. Yang LB, Chu JS, Fix JA. Colon-specific drug delivery: new approaches and in vitro/in vivo evaluation. International Journal of Pharmaceutics 235, 1–15, 2002